{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:51:58Z","timestamp":1782370318334,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T00:00:00Z","timestamp":1717891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ijid.2024.107134","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:45:27Z","timestamp":1719531927000},"page":"107134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients"],"prefix":"10.1016","volume":"146","author":[{"given":"Emi","family":"Takashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6129-8950","authenticated-orcid":false,"given":"Seiichiro","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideka","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2024.107134_bib0001","doi-asserted-by":"crossref","first-page":"e13090","DOI":"10.1111\/irv.13090","article-title":"Are twindemics occurring?","volume":"17","author":"Takashita","year":"2023","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.ijid.2024.107134_bib0002","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.39.2300501","article-title":"A community cluster of influenza A(H3N2) virus infection with reduced susceptibility to baloxavir due to a PA E199G substitution in Japan, February to March 2023","volume":"28","author":"Takashita","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2024.107134_bib0003","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.ijid.2024.107134_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105281","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020","volume":"200","author":"Govorkova","year":"2022","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2024.107134_bib0005","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41422-022-00640-y","article-title":"The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition","volume":"32","author":"Sacco","year":"2022","journal-title":"Cell Res"},{"key":"10.1016\/j.ijid.2024.107134_bib0006","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.ijid.2024.107134_bib0007","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1038\/s41598-021-91662-w","article-title":"Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant","volume":"11","author":"Ilmj\u00e4rv","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2024.107134_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113077","article-title":"SARS-CoV-2 variants with NSP12 P323L\/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility","volume":"42","author":"Kim","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ijid.2024.107134_bib0009","unstructured":"World Health Organization. Summary of neuraminidase (NA) amino acid substitutions associated with reduced inhibition by neuraminidase inhibitors (NAIs), https:\/\/www.who.int\/publications\/m\/item\/summary-of-neuraminidase-(na)-amino-acid-substitutions-associated-with-reduced-inhibition-by-neuraminidase-inhibitors-(nais); 2023 [accessed 17 July 2024]."},{"key":"10.1016\/j.ijid.2024.107134_bib0010","unstructured":"World Health Organization. Summary of polymerase acidic (PA) protein amino acid substitutions analysed for their effects on baloxavir susceptibility, https:\/\/www.who.int\/publications\/m\/item\/summary-of-polymerase-acidic-(pa)-protein-amino-acid-substitutions-analysed-for-their-effects-on-baloxavir-susceptibility; 2023 [accessed 17 July 2024]."},{"key":"10.1016\/j.ijid.2024.107134_bib0011","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMc2201933","article-title":"Efficacy of antiviral agents against the SARS-CoV-2 Omicron subvariant BA.2","volume":"386","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2024.107134_bib0012","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3390\/pathogens9090725","article-title":"In vitro characterization of multidrug-resistant influenza A(H1N1)pdm09 viruses carrying a dual neuraminidase mutation isolated from immunocompromised patients","volume":"9","author":"Takashita","year":"2020","journal-title":"Pathogens"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971224002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T17:27:09Z","timestamp":1728494829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971224002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":12,"alternative-id":["S1201971224002054"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107134","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2024.107134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107134"}}